REACH Only Representative (OR) Strategy: When US Companies Need It in 2025



REACH Only Representative (OR) Strategy: When US Companies Need It in 2023

Published on 21/12/2025

REACH Only Representative (OR) Strategy: When US Companies Need It in 2023

The European Union’s Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation imposes a broad range of obligations on companies that manufacture or import chemicals within the EU. This regulatory environment can be particularly challenging for United States-based organizations that want to engage in the European market. A critical aspect of navigating these rules is understanding the concept of an Only Representative (OR). This article serves as a step-by-step guide for US companies on the principles and practices associated with the REACH Only Representative strategy.

Step 1: Understanding EU REACH Compliance

To comply with EU REACH regulations, it is essential to grasp its fundamental components. Specifically, the REACH framework is designed to ensure the safe use of chemical substances and to promote the progressive replacement of substances of very high concern (SVHCs) with safer alternatives. The regulation requires that individuals or companies who manufacture or import chemicals in quantities of 1 tonne

or more per year submit a registration dossier to the European Chemicals Agency (ECHA).

The first critical information you must gather for compliance includes:

  • Substance Identification: Any chemicals subject to REACH must be appropriately identified, including their chemical identity and any relevant properties.
  • Safety Data Sheet (SDS): The submission of an SDS is essential, which contains relevant data about the chemical, its uses, and safety measures.
  • Risk Assessment: Companies must conduct a risk assessment of the substances, evaluating the potential hazards and the resulting implications for human health and the environment.

All US companies wanting to sell chemical substances in Europe should familiarize themselves with these components to understand what is required in the registration process. The key takeaway is to ensure all chemical substances are registered adequately to avoid penalties and to maintain market access.

Step 2: Identifying the Need for an Only Representative

The concept of an Only Representative (OR) is critical for non-EU manufacturers. According to Article 8 of the REACH regulation, any non-EU company can appoint an Only Representative based located within the EU to fulfill its registration obligations. This is particularly beneficial for US companies as it alleviates the burden of establishing a physical entity within the EU.

Also Read:  SVHC Communication and SCIP Database Readiness: Practical Workflow for US Suppliers in 2025

In determining the need for an OR, consider the following:

  • Volume of Chemical Export: If your US business plans to export chemical substances to the EU in quantities of 1 tonne or more per year, appointing an OR is advisable.
  • Variety of Chemicals Affected: Assess the different chemicals in your supply chain and whether their registrations are compliant. Multiple substances might necessitate clearer compliance strategies.
  • Market Access Obligations: If your business model relies heavily on the European market, an OR will ensure that your company can legally operate without the risk of REACH non-compliance.

Choosing an Only Representative is not merely a matter of convenience; it is a key regulatory strategy that ensures compliance with REACH while mitigating logistical challenges associated with direct registration.

Step 3: Selecting a Qualified Only Representative

Once the decision to appoint an Only Representative is affirmed, the next important task is selecting a qualified individual or firm. This selection is pivotal, as your OR will be responsible for ensuring compliance with REACH regulations, thereby directly influencing your access to the EU market.

Consider the following criteria when selecting an OR:

  • Experience and Expertise: The OR should have a demonstrated understanding of REACH and other relevant EU regulations. Their experience in regulatory matters will prove invaluable.
  • Understanding of Chemical Classifications: The chosen representative should be knowledgeable about the particular chemicals involved, including any potential risks associated with the substances.
  • Reputation and References: Research the OR’s track record. Seek references from other clients, especially those in the chemical sector. This provides assurance of their reliability and professionalism.
  • Services Offered: Evaluate the full range of services available through the OR, including support with dossier preparation, safety data sheets, and compliance updates as regulations evolve.

It’s critical to finalize an agreement that outlines the OR’s responsibilities, fees, and other pertinent details. Clarity in this relationship ensures that both parties understand the obligations involved in maintaining compliance.

Step 4: Preparing the Registration Dossier

With a qualified Only Representative selected, the next phase is the preparation of the registration dossier. This dossier is the foundation of your REACH compliance obligations and must be meticulously compiled to satisfy ECHA’s requirements.

The registration dossier must include:

  • Technical Information: Details about the chemical substance, including chemical structure, properties, and a comprehensive evaluation of uses and exposure scenarios.
  • SDS: An up-to-date Safety Data Sheet for the chemical being registered is necessary. This document should align with the requirements outlined in REACH Annex II.
  • Risk Management Measures: An explanation or documentation of risk management measures taken to limit exposure to hazardous substances should be included in the dossier.
  • Data on Chemical Characterization: Provide robust data that demonstrates the safety and effectiveness of the chemical in question, especially when SVHCs are involved.
Also Read:  Supply Chain Obligations Under REACH: Pharma Case Study

Once prepared, the registration dossier must be submitted electronically via ECHA’s REACH-IT system. The dossier submissions should be thorough, as incomplete or incorrect submissions can result in delays, additional requests for information, or even penalties. Early preparation mitigates these risks significantly.

Step 5: Navigating the Review Process

Upon submission of the registration dossier, it enters a review phase conducted by ECHA. This critical process can take anywhere from a few weeks to several months, depending on the complexity of the dossier and the volume of submissions ECHA is processing at the time.

Understanding the implications of this phase is essential:

  • Cooperation with ECHA: Be prepared to respond to inquiries and additional requests for information from ECHA. This ongoing dialogue is essential to demonstrate compliance effectively.
  • Addressing Potential Non-Conformities: If ECHA identifies any gaps or non-conformities in your registration, your OR should work swiftly to address these issues. Non-compliance could halt or restrict market access.
  • Preparation for Audits: As part of compliance, be ready for an audit by ECHA; your records and documentation must be well-organized for scrutiny.

This step requires an ongoing commitment from both the US company and the Only Representative to ensure the process runs smoothly. Maintaining open lines of communication and persisting in compliance contributes to a successful review process.

Step 6: Ensuring Ongoing Compliance and Post-Approval Activities

Once the registration is approved, the compliance journey does not end. Continuous compliance with REACH regulations is vital. Regulatory obligations may change, and your company must adapt accordingly.

Key areas to focus on for ongoing compliance include:

  • Updates to Safety Data Sheets: Ensure that updated SDSs reflect any new information regarding the substances you are handling, including any modifications in risk assessment or safety measures.
  • Communications with Your Supply Chain: Keep open channels with suppliers regarding potential changes in substance composition or regulatory status. This transparency is crucial for avoiding compliance pitfalls.
  • Monitoring Regulatory Changes: Remain vigilant concerning updates to REACH or related regulations that might affect your registration and compliance status. Regular training and updates on these topics should be a priority for your team.
  • Documentation of Compliance Activities: Keep meticulous records of all compliance-related activities, communications, and updates. This comprehensive documentation serves as essential evidence in case of inquiries or verifications by regulatory authorities.
Also Read:  EU REACH Updates 2025: Key Changes Pharma Should Monitor

Lastly, ensure that ongoing assessments of your chemicals are conducted. If substances are classified as SVHCs, be prepared to fulfill additional obligations under the SCIP database by notifying waste authorities and submitting relevant notifications.

Conclusion

Guiding a US company through the complexities of EU REACH compliance necessitates careful planning, strategic choices regarding the appointment of an Only Representative, and a commitment to maintain rigorous documentation and updated communication practices. Every step, from understanding the initial obligations to ensuring ongoing compliance, informs your readiness to access the crucial European market without facing legal repercussions.

In conclusion, carrying out these steps systematically will help you to not only navigate EU regulations effectively but also strengthen your organization’s position in supply chain compliance. By following this structured guide, US companies can confidently approach EU REACH compliance, thus facilitating sustainable growth and adherence to environmental regulations.